Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Genetic Link Found for Physical and Psychological Disorders

By LabMedica International staff writers
Posted on 22 Mar 2018
Print article
Image: GWAS results: an illustration of a Manhattan plot depicting several strongly associated risk loci. Each dot represents a SNP, with the X-axis showing genomic location and Y-axis showing association level (Photo courtesy of Wikimedia Commons).
Image: GWAS results: an illustration of a Manhattan plot depicting several strongly associated risk loci. Each dot represents a SNP, with the X-axis showing genomic location and Y-axis showing association level (Photo courtesy of Wikimedia Commons).
Results of a series of genome-wide association studies have indicated that insomnia is at least partially hereditary and that it is linked to physical and psychological disorders such as depression and type II diabetes.

Based on earlier genomic studies that had demonstrated the heritability of insomnia, investigators at the University of California, San Diego (USA) conducted genome-wide association studies (GWAS) on DNA samples obtained from more than 33,000 soldiers participating in the Army Study to Assess Risk and Resilience in Servicemembers (STARRS). For this study, GWAS were carried out separately for each ancestral group (EUR, AFR, LAT).

Results published in the March 8, 2018, online edition of the journal Molecular Psychiatry revealed that heritability (SNP-based) for lifetime insomnia disorder was significant. Genetic contributions to insomnia disorder in STARRS were significantly positively correlated with major depressive disorder and type II diabetes, and negatively with morningness chronotype and subjective wellbeing.

In addition, the study identified a genome-wide significant locus on chromosome seven and a genome-wide significant gene-based association in the EUR group on chromosome nine.

"Several of these variants rest comfortably among locations and pathways already known to be related to sleep and circadian rhythms," said senior author Dr. Murray Stein, professor of psychiatry, family medicine, and public health at the University of California, San Diego. "Such insomnia associated loci may contribute to the genetic risk underlying a range of health conditions including psychiatric disorders and metabolic disease. The genetic correlation between insomnia disorder and other psychiatric disorders, such as major depression, and physical disorders such as type II diabetes suggests a shared genetic diathesis for these commonly co-occurring phenotypes. A better understanding of the molecular bases for insomnia will be critical for the development of new treatments."

Related Links:
University of California, San Diego

Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
FOB+Transferrin+Calprotectin+Lactoferrin Test
CerTest FOB+Transferrin+Calprotectin+Lactoferrin Combo Test
New
Malondialdehyde HPLC Test
Malondialdehyde in Serum/Plasma – HPLC

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.